| Line Item | 2024-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.9M | +15.5% | +54.5% |
| Cost of Revenue | $8.9M | +26.6% | +147.8% |
| R&D Expense | $4.9M | +65.8% | -52.4% |
| SG&A Expense | $12.8M | -23.3% | -31.7% |
| Operating Income | -$17.4M | +2.3% | +39.2% |
| Pre-tax Income | -$17.1M | -0.7% | +37.5% |
| Income Tax | $0 |
| Line Item | 2024-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $82.6M | -5.6% | +46.7% |
| Accounts Receivable | $10.9M | -14.4% | +57.6% |
| Inventory | $13.3M | +13.1% | -40.1% |
| Current Assets | $149.8M | -12.4% | -35.3% |
| Total Assets | $213.5M | -7.4% | -26.3% |
| Current Liabilities |
| Line Item | 2024-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$62.0M | — | — |
| Capital Expenditures | $230K | — | — |
| Investing Cash Flow | $71.9M | — | — |
| Financing Cash Flow | -$22.0M | — | — |
| Free Cash Flow | -$62.2M | — | — |
| — |
| — |
| Net Income | -$17.1M | -0.7% | +37.5% |
| EPS (Basic) | -$0.11 | +0.0% | +31.3% |
| EPS (Diluted) | -$0.11 | +0.0% | +31.3% |
| $55.5M |
| -7.9% |
| -27.3% |
| Long-term Debt | $5.8M | — | — |
| Total Liabilities | $86.1M | -2.0% | -19.1% |
| Stockholders' Equity | $127.4M | -10.7% | -30.4% |